Inhibition of matrix metalloproteinase-3 synthesis in human conjunctival fibroblasts by interleukin-4 or interleukin-13

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 7, 2006, Pages 2857-2864

  Fukuda, Ken ^a,b   Fujitsu, Youichiro ^a   Kumagai, Naoki ^a   Nishida, Teruo ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; STROMELYSIN; BLOCKING ANTIBODY; INTERLEUKIN 4 RECEPTOR; MESSENGER RNA; METALLOPROTEINASE; MMP3 PROTEIN, HUMAN; PROSTAGLANDIN E2; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFECT; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERNAL CONJUNCTIVITIS; CULTURE TECHNIQUE; CYTOLOGY; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; TH2 CELL; UPREGULATION;

ANTIBODIES, BLOCKING; CELL CULTURE TECHNIQUES; CONJUNCTIVA; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOBLOTTING; INTERLEUKIN-13; INTERLEUKIN-4; MATRIX METALLOPROTEINASE 3; METALLOPROTEASES; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, INTERLEUKIN-4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TH2 CELLS; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 33746666084     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-1261     Document Type: Article

References (56)

1. Maggi E, Biswas P, Del Prete G, et al. Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol. 1991;146:1169-1174.
2. Fujishima H, Takeuchi T, Shinozaki N, Saito I, Tsubota K. Measurement of IL-4 in tears of patients with seasonal allergic conjunctivitis and vernal keratoconjunctivitis. Clin Exp Immunol. 1995;102:395-398.
3. Uchio E, Ono SY, Ikezawa Z, Ohno S. Tear levels of interferon-gamma, interleukin (IL) -2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin Exp Allergy. 2000;30:103-109.
4. Leonardi A, Borghesan F, DePaoli M, Plebani M, Secchi AG. Procollagens and inflammatory cytokine concentrations in tarsal and limbal vernal keratoconjunctivitis. Exp Eye Res. 1998;67:105-112.
5. Leonardi A, Brun P, Tavolato M, et al. Growth factors and collagen distribution in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2000;41:4175-4181.
6. Abu el-Asrar AM, Geboes K, al-Kharashi SA, et al. An immunohistochemical study of collagens in trachoma and vernal keratoconjunctivitis. Eye. 1998;12:1001-1006.
7. Abu El-Asrar AM, Meersschaert A, Al-Kharashi SA, Missotten L, Geboes K. Immuno-histochemical evaluation of conjunctival remodelling in vernal keratoconjunctivitis. Eye. 2003;17:767-771.
8. Leonardi A, Abatangelo G, Cortivo R, Secchi AG. Collagen types I and III in giant papillae of vernal keratoconjunctivitis. Br J Ophthalmol. 1995;79:482-485.
9. Fujitsu Y, Fukuda K, Kimura K, et al. Protection of human conjunctival fibroblasts from NO-induced apoptosis by interleukin-4 or interleukin-13. Invest Ophthalmol Vis Sci. 2005;46:797-802.
10. Fujitsu Y, Fukuda K, Kumagai N, Nishida T. IL-4-induced cell proliferation and production of extracellular matrix proteins in human conjunctival fibroblasts. Exp Eye Res. 2003;76:107-114.
11. Abu El-Asrar AM, Van Aelst I, Al-Mansouri S, et al. Gelatinase B in vernal keratoconjunctivitis. Arch Ophthalmol. 2001;119:1505-1511.
12. Kumagai N, Yamamoto K, Fukuda K, et al. Active matrix metalloproteinases in the tear fluid of individuals with vernal keratoconjunctivitis. J Allergy Clin Immunol. 2002;110:489-491.
13. Leonardi A, Brun P, Abatangelo G, Plebani M, Secchi AG. Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2003;44:3052-3058.
14. Lijnen HR, Arza B, Van Hoef B, Collen D, Declerck PJ. Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3). J Biol Chem. 2000;275:37645-37650.
15. Murphy G, Cockett MI, Stephens PE, Smith BJ, Docherty AJ. Stromelysin is an activator of procollagenase: a study with natural and recombinant enzymes. Biochem J. 1987;248:265-268.
16. Tuter G, Kurtis B, Serdar M, et al. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1. J Clin Periodontol. 2005;32:1011-1015.
17. van Meurs J, van Lent P, Holthuysen A, et al. Active matrix metalloproteinases are present in cartilage during immune complex-mediated arthritis: a pivotal role for stromelysin-1 in cartilage destruction. J Immunol. 1999;163:5633-5639.
18. Beaudeux JL, Giral P, Bruckert E, et al. Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia. Atherosclerosis. 2003;169:139-146.
19. Nikkola J, Vihinen P, Vlaykova T, et al. High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma. Int J Cancer. 2002;97:432-438.
20. Meller D, Li DQ, Tseng SC. Regulation of collagenase, stromelysin, and gelatinase B in human conjunctival and conjunctivochalasis fibroblasts by interleukin-1β and tumor necrosis factor-α. Invest Ophthalmol Vis Sci. 2000;41:2922-2929.
21. Keane-Myers AM, Miyazaki D, Liu G, et al. Prevention of allergic eye disease by treatment with IL-1 receptor antagonist. Invest Ophthalmol Vis Sci. 1999;40:3041-3046.
22. Xue ML, Wakefield D, Willcox MD, et al. Regulation of MMPs and TIMPs by IL-1β during corneal ulceration and infection. Invest Ophthalmol Vis Sci. 2003;44:2020-2025.
23. Fukuda K, Kumagai N, Yamamoto K, et al. Potentiation of lipopolysaccharide-induced chemokine and adhesion molecule expression in corneal fibroblasts by soluble CD14 or LPS-binding protein. Invest Ophthalmol Vis Sci. 2005;46:3095-3101.
24. Bond M, Chase AJ, Baker AH, Newby AC. Inhibition of transcription factor NF-κB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res. 2001;50:556-565.
25. Quinones S, Buttice G, Kurkinen M. Promoter elements in the transcriptional activation of the human stromelysin-1 gene by the inflammatory cytokine, interleukin 1. Biochem J. 1994;302:471-477.
26. Noguchi K, Shitashige M, Watanabe H, Murota S, Ishikawa I. Interleukin-4 and interferon-γ inhibit prostaglandin production by interleukin-1β- stimulated human periodontal ligament fibroblasts. Inflammation. 1999;23:1-13.
27. Domeij H, Yucel-Lindberg T, Modeer T. Signal pathways involved in the production of MMP-1 and MMP-3 in human gingival fibroblasts. Eur J Oral Sci. 2002;110:302-306.
28. 2 generation through suppression of cyclooxygenase-2 expression in human fibroblasts. Cytokine. 2000;12:603-612.
29. Sugiyama E, Taki H, Kuroda A, et al. Interleukin-4 inhibits prostaglandin E2 production by freshly prepared adherent rheumatoid synovial cells via inhibition of biosynthesis and gene expression of cyclo-oxygenase II but not of cyclo-oxygenase I. Ann Rheum Dis. 1996;55:375-382.
30. Leonardi A, Cortivo R, Fregona I, et al. Effects of Th2 cytokines on expression of collagen, MMP-1, and TIMP-1 in conjunctival fibroblasts. Invest Ophthalmol Vis Sci. 2003;44:183-189.
31. Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF Jr. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest. 1989;84:678-685.
32. Ihn H, Yamane K, Asano Y, Kubo M, Tamaki K. IL-4 up-regulates the expression of tissue inhibitor of metalloproteinase-2 in dermal fibroblasts via the p38 mitogen-activated protein kinase dependent pathway. J Immunol. 2002;168:1895-1902.
33. Fukuda K, Kumagai N, Fujitsu Y, Nishida T. Fibroblasts as local immune modulators in ocular allergic disease. Allergol Int. 2006;55:121-129.
34. Anwar AR, Moqbel R, Walsh GM, Kay AB, Wardlaw AJ. Adhesion to fibronectin prolongs eosinophil survival. J Exp Med. 1993;177:839-843.
35. Bianchine PJ, Burd PR, Metcalfe DD. IL-3-dependent mast cells attach to plate-bound vitronectin: demonstration of augmented proliferation in response to signals transduced via cell surface vitronectin receptors. J Immunol. 1992;149:3665-3671.
36. Walsh GM, Wardlaw AJ. Dexamethasone inhibits prolonged survival and autocrine granulocyte-macrophage colony-stimulating factor production by human eosinophils cultured on laminin or tissue fibronectin. J Allergy Clin Immunol. 1997;100:208-215.
37. Higashimoto I, Chihara J, Kakazu T, et al. Adhesion to fibronectin augments eosinophil radical oxygen products. Int Arch Allergy Immunol. 1995;108(suppl 1):48-49.
38. Higashimoto I, Chihara J, Kawabata M, Nakajima S, Osame M. Adhesion to fibronectin regulates expression of intercellular adhesion molecule-1 on eosinophilic cells. Int Arch Allergy Immunol. 1999;120(suppl 1):34 -37.
39. Kruger-Krasagakes S, Grutzkau A, Krasagakis K, Hoffmann S, Henz BM. Adhesion of human mast cells to extracellular matrix provides a co-stimulatory signal for cytokine production. Immunology. 1999;98:253-257.
40. Munoz NM, Rabe KF, Neeley SP, et al. Eosinophil VLA-4 binding to fibronectin augments bronchial narrowing through 5-lipoxygenase activation. Am J Physiol. 1996;270:L587-L594.
41. Vaday GG, Lider O. Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation. J Leukoc Biol. 2000;67:149-159.
42. Roberts R, Gallagher J, Spooncer E, et al. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature. 1988;332:376-378.
43. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature. 1990;346:281-284.
44. Bond M, Baker AH, Newby AC. Nuclear factor κB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts. Biochem Biophys Res Commun. 1999;264:561-567.
45. Frisch SM, Ruley HE. Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. J Biol Chem. 1987;262:16300-16304.
46. Stein B, Baldwin AS Jr, Ballard DW, et al. Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 1993;12:3879-3891.
47. 2 gene expression and tissue remodeling. J Cell Biol. 1998;140:709-719.
48. Jenkins K, Javadi M, Borghaei RC. Interleukin-4 suppresses IL-1-induced expression of matrix metalloproteinase-3 in human gingival fibroblasts. J Periodontol. 2004;75:283-291.
49. Donnelly RP, Crofford LJ, Freeman SL, et al. Tissue-specific regulation of IL-6 production by IL-4: differential effects of IL-4 on nuclear factor-κB activity in monocytes and fibroblasts. J Immunol. 1993;151:5603-5612.
50. Borghaei RC, Rawlings PL Jr, Mochan E. Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts. Arthritis Rheum. 1998;41:1398-1406.
51. Fukuda K, Fujitsu Y, Kumagai N, Nishida T. Characterization of the interleukin-4 receptor complex in human corneal fibroblasts. Invest Ophthalmol Vis Sci. 2002;43:183-188.
52. Gingras S, Simard J, Groner B, Pfitzner E. p300/CBP is required for transcriptional induction by interleukin-4 and interacts with Stat6. Nucleic Acids Res. 1999;27:2722-2729.
53. Smits PH, de Wit L, van der Eb AJ, Zantema A. The adenovirus E1A-associated 300 kDa adaptor protein counteracts the inhibition of the collagenase promoter by E1A and represses transformation. Oncogene. 1996;12:1529-1535.
54. Wadgaonkar R, Phelps KM, Haque Z, et al. CREB-binding protein is a nuclear integrator of nuclear factor-κB and p53 signaling. J Biol Chem. 1999;274:1879-1882.
55. Sheppard KA, Rose DW, Haque ZK, et al. Transcriptional activation by NF-κB requires multiple coactivators. Mol Cell Biol. 1999;19:6367-6378.
56. Horvai AE, Xu L, Korzus E, et al. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci USA. 1997;94:1074-1079.